Article
Considerations on implementation of the newest treatment for symptomatic uterine fibroids: oral GnRH antagonists.
2023-02-23
Abstract excerpt
Novel Gonadotrophin Releasing Hormone (GnRH) antagonist treatments have recently been developed in combination with hormonal add-back therapy, as an oral treatment option for women suffering from uterine fibroids. Registration trials assessing the GnRH antagonist combination preparations with relugolix, elagolix, and linzagolix have assessed treatment efficacy for fibroid related heavy menstrual blood loss in comp...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- aab3b1fe-6c8a-5fc6-92e3-8ae2f5587d08
- DOI
- 10.22541/au.167716085.54111521/v1
